Open Access

Sirtuin 6 regulates the proliferation and survival of clear cell renal cell carcinoma cells via B‑cell lymphoma 2

  • Authors:
    • Jun An
    • Jieping Yang
    • Yang Yao
    • Kaining Lu
    • Zhiqiang Zhao
    • Meng Yu
    • Yuyan Zhu
  • View Affiliations

  • Published online on: February 17, 2021     https://doi.org/10.3892/ol.2021.12554
  • Article Number: 293
  • Copyright: © An et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Sirtuin 6 (SIRT6) is a member of the third family of longevity proteins (SIRTs) that is involved in the development of different types of cancer. However, the potential role of SIRT6 in clear cell renal cell carcinoma (ccRCC) and its molecular mechanism have not yet been fully elucidated. Therefore, the present study aimed to investigate the association between SIRT6 and ccRCC, and to further examine the underlying mechanism of its effect on ccRCC proliferation, using bioinformatics analysis, and in vitro and in vivo experiments. The results of the present study demonstrated that SIRT6 was upregulated in ccRCC tissues. In addition, bioinformatics analysis revealed that high SIRT6 expression was closely associated with poor prognosis of patients with ccRCC. In vitro experiments demonstrated that silencing SIRT6 expression in ccRCC‑derived 769‑P and 786‑O cells significantly inhibited their proliferation, migration and invasion. Consistent with these results, in vivo assays demonstrated that SIRT6 knockdown markedly attenuated tumor growth arising from 769‑P cells. Furthermore, depletion of SIRT6 enhanced the sensitivity of ccRCC cells to cisplatin. Notably, silencing SIRT6 expression decreased B‑cell lymphoma 2 (Bcl‑2) expression and increased Bax expression, respectively. Taken together, these results suggest that SIRT6 acts as a proto‑oncogene in ccRCC through the augmentation of the Bcl‑2‑dependent pro‑survival pathway, and may be used as a therapeutic target for patients with ccRCC.
View Figures
View References

Related Articles

Journal Cover

April-2021
Volume 21 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
An J, Yang J, Yao Y, Lu K, Zhao Z, Yu M and Zhu Y: Sirtuin 6 regulates the proliferation and survival of clear cell renal cell carcinoma cells via B‑cell lymphoma 2. Oncol Lett 21: 293, 2021.
APA
An, J., Yang, J., Yao, Y., Lu, K., Zhao, Z., Yu, M., & Zhu, Y. (2021). Sirtuin 6 regulates the proliferation and survival of clear cell renal cell carcinoma cells via B‑cell lymphoma 2. Oncology Letters, 21, 293. https://doi.org/10.3892/ol.2021.12554
MLA
An, J., Yang, J., Yao, Y., Lu, K., Zhao, Z., Yu, M., Zhu, Y."Sirtuin 6 regulates the proliferation and survival of clear cell renal cell carcinoma cells via B‑cell lymphoma 2". Oncology Letters 21.4 (2021): 293.
Chicago
An, J., Yang, J., Yao, Y., Lu, K., Zhao, Z., Yu, M., Zhu, Y."Sirtuin 6 regulates the proliferation and survival of clear cell renal cell carcinoma cells via B‑cell lymphoma 2". Oncology Letters 21, no. 4 (2021): 293. https://doi.org/10.3892/ol.2021.12554